{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:12:07Z","timestamp":1780503127895,"version":"3.54.1"},"reference-count":41,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"unspecified","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014343","name":"National Tea Research Foundation","doi-asserted-by":"publisher","award":["17 (408)\/2017\/6511"],"award-info":[{"award-number":["17 (408)\/2017\/6511"]}],"id":[{"id":"10.13039\/501100014343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2(23)\/OBS\/2022-NCD-II"],"award-info":[{"award-number":["3\/1\/2(23)\/OBS\/2022-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF180004"],"award-info":[{"award-number":["IF180004"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,3,29]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2D) accelerates the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) to hepatic fibrosis, and a subset of MASLD subjects has T2D. Identification of molecular mediators linking T2D and MASLD progression remains unmet. Studies revealed patients with steatohepatitis have lower hepatic Mitogen inducible gene-6 (Mig-6) expression, and Mig-6 gene silencing causes hyperglycemia in a preclinical study. However, the relationship between Mig-6 and dysglycemia in MASLD, including its association with pancreatic \u03b2-cell dysfunction, is unknown. We assessed serum Mig-6 level in MASLD with or without dysglycemia, and its association with Homeostasis Model Assessment of \u03b2-cell function (HOMA-\u03b2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fibrosis 4 Index (FIB-4) score was calculated in 479 MASLD patients; those scoring 1.3\u20132.67\u2009underwent liver vibration-controlled transient elastography for fibrosis assessment. F2 and F3 fibrosis subjects (119) were classified as normal glucose tolerance (NGT) (35), impaired glucose tolerance (44), and treatment-na\u00efve T2D (40), as per American Diabetes Association criteria. Serum Mig-6 levels were measured by ELISA. Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and HOMA-\u03b2 were computed using serum C peptide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Metabolic syndrome was present in 68% and 27% of participants with FIB-4&gt;1.3\u2009and &lt;1.3, respectively. Reduced serum Mig-6 level was observed in the FIB-4 score &gt;1.3 group. Participants with dysglycemia had lower (p&lt;0.05) serum Mig-6 levels compared with NGT. Mig-6 showed a negative correlation with fasting plasma glucose, hemoglobin A1C and HOMA-IR and a positive correlation with HOMA-\u03b2. A cut-off value of serum Mig-6 level &lt;97.49\u2009pg\/mL predicted dysglycemia in metabolic dysfunction-associated steatohepatitis (sensitivity 77.50%, specificity 73.08%, receiver operating characteristic analysis curve). 74.2% of the treatment-na\u00efve T2D subjects had a low serum Mig-6, compared with 22% of subjects with NGT. HOMA-\u03b2 was lower in the group having Mig-6 below the cut-off level (97.49\u2009pg\/mL). Positive predictive and negative predictive values of Mig-6 in identifying pancreatic \u03b2-cell dysfunction were 79.41% and 85.17%,\u2009respectively. For patients having HOMA-IR&gt;1.6, corresponding values were 80% and 86.67%,\u2009respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum Mig-6 levels may identify MASLD patients at an increased risk of dysglycemia and positively correlate with pancreatic \u03b2-cell dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2026-005947","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:25:14Z","timestamp":1780500314000},"page":"e005947","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced circulating Mig-6 levels are associated with dysglycemia in metabolic dysfunction associated steatotic liver disease (MASLD)"],"prefix":"10.1136","volume":"14","author":[{"given":"Bidisha","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiranjit","family":"Bose","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasish","family":"Pramanik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadip","family":"Kundu","sequence":"additional","affiliation":[{"name":"CSIR - Indian Institute of Chemical Biology, Kolkata, West Bengal, India"},{"name":"Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India"},{"name":"Howard Hughes Medical Institute, Chevy Chase, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Mondal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sib Sankar","family":"Roy","sequence":"additional","affiliation":[{"name":"CSIR - Indian Institute of Chemical Biology, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8033-5748","authenticated-orcid":false,"given":"Satinath","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026060308250534000_14.3.e005947.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.05.019"},{"key":"2026060308250534000_14.3.e005947.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1909301"},{"key":"2026060308250534000_14.3.e005947.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"2026060308250534000_14.3.e005947.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.07.004"},{"key":"2026060308250534000_14.3.e005947.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.014"},{"key":"2026060308250534000_14.3.e005947.6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026060308250534000_14.3.e005947.7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep"},{"key":"2026060308250534000_14.3.e005947.8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026060308250534000_14.3.e005947.9","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0707"},{"key":"2026060308250534000_14.3.e005947.10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13340-024-00783-w","article-title":"Pathophysiological hallmarks in type 2 diabetes heterogeneity (review)","volume":"16","author":"Datta","year":"2025","journal-title":"Diabetol Int"},{"key":"2026060308250534000_14.3.e005947.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-020-01204-y","article-title":"Dyslipidemia and cardiovascular disease risk among the MASHAD study population","volume":"19","author":"Hedayatnia","year":"2020","journal-title":"Lipids Health Dis"},{"key":"2026060308250534000_14.3.e005947.12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17925\/EE.2024.20.2.2","article-title":"Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy","volume":"20","author":"Leith","year":"2024","journal-title":"touchREV Endocrinol"},{"key":"2026060308250534000_14.3.e005947.13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"2026060308250534000_14.3.e005947.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1997"},{"key":"2026060308250534000_14.3.e005947.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"2026060308250534000_14.3.e005947.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2021.07.002"},{"key":"2026060308250534000_14.3.e005947.17","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3074"},{"key":"2026060308250534000_14.3.e005947.18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408907200"},{"key":"2026060308250534000_14.3.e005947.19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206516"},{"key":"2026060308250534000_14.3.e005947.20","doi-asserted-by":"publisher","DOI":"10.1242\/dev.032979"},{"key":"2026060308250534000_14.3.e005947.21","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/549054","article-title":"Mig-6 gene knockout induces neointimal hyperplasia in the vascular smooth muscle cell","volume":"2014","author":"Lee","year":"2014","journal-title":"Dis Markers"},{"key":"2026060308250534000_14.3.e005947.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30696"},{"key":"2026060308250534000_14.3.e005947.23","first-page":"5","article-title":"The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction","volume":"3","author":"Akhtar","year":"2013","journal-title":"Bioimpacts"},{"key":"2026060308250534000_14.3.e005947.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07057-z","article-title":"Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma","volume":"20","author":"Kang","year":"2020","journal-title":"BMC Cancer"},{"key":"2026060308250534000_14.3.e005947.25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209790"},{"key":"2026060308250534000_14.3.e005947.26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/1753-0407.12261","article-title":"Role of Mig-6 in hepatic glucose metabolism","volume":"8","author":"Yoo","year":"2016","journal-title":"J Diabetes"},{"key":"2026060308250534000_14.3.e005947.27","doi-asserted-by":"crossref","first-page":"1632061","DOI":"10.1155\/2016\/1632061","article-title":"Fatty Liver and Insulin Resistance in the Liver-Specific Knockout Mice of Mitogen Inducible Gene-6","volume":"2016","author":"Park","year":"2016","journal-title":"J Diabetes Res"},{"key":"2026060308250534000_14.3.e005947.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100780","article-title":"Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study","volume":"36","author":"Anstee","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026060308250534000_14.3.e005947.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02290-1","article-title":"Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups","volume":"22","author":"Sugiyama","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"2026060308250534000_14.3.e005947.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66210-x","article-title":"Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis","volume":"14","author":"Mignot","year":"2024","journal-title":"Sci Rep"},{"key":"2026060308250534000_14.3.e005947.31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N"},{"key":"2026060308250534000_14.3.e005947.32","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0190"},{"key":"2026060308250534000_14.3.e005947.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2022.11.014"},{"key":"2026060308250534000_14.3.e005947.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-015-0730-3"},{"key":"2026060308250534000_14.3.e005947.35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5005\/jp-journals-10071-24043","article-title":"Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome","volume":"25","author":"Sama","year":"2021","journal-title":"Indian J Crit Care Med"},{"key":"2026060308250534000_14.3.e005947.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042915","article-title":"Mig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis","volume":"7","author":"Ku","year":"2012","journal-title":"PLoS One"},{"key":"2026060308250534000_14.3.e005947.37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2021.07.088","article-title":"Mig-6 is essential for glucose homeostasis and thermogenesis in brown adipose tissue","volume":"572","author":"Choung","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"2026060308250534000_14.3.e005947.38","doi-asserted-by":"publisher","DOI":"10.22088\/IJMCM.BUMS.8.2.49"},{"key":"2026060308250534000_14.3.e005947.39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88881"},{"key":"2026060308250534000_14.3.e005947.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341207"},{"key":"2026060308250534000_14.3.e005947.41","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-28032012000100015"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2026-005947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:25:17Z","timestamp":1780500317000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2026-005947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,3]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjdrc-2026-005947"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2026-005947","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}